Do New Hospital Price Transparency Regulations Reflect Value in Arthroplasty?

Rising Prices and Health Care “Empires”

(2020) Andrew B. Bindman   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Do Patient Point of Entry and Medicaid Status Affect Quality Outcomes Following Total Knee Arthroplasty?

(2020) James E. Feng et al.   JOURNAL OF ARTHROPLASTY

Price Transparency: Empowering Patient Choice and Promoting Provider Competition

(2020) Brian J. Miller et al.   JOURNAL OF MEDICAL SYSTEMS

Analysis of Price Transparency via National Cancer Institute–Designated Cancer Centers’ Chargemasters for Prostate Cancer Radiation Therapy

(2020) Ankit Agarwal et al.   JAMA Oncology

Costs and Outcomes of Medicare Advantage and Traditional Medicare Beneficiaries After Total Hip and Knee Arthroplasty

(2019) Michael F. Yayac et al.   JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS

Market Share Matters: Evidence Of Insurer And Provider Bargaining Over Prices

(2017) Eric T. Roberts et al.   HEALTH AFFAIRS

Offering A Price Transparency Tool Did Not Reduce Overall Spending Among California Public Employees And Retirees

(2017) Sunita Desai et al.   HEALTH AFFAIRS

Examining A Health Care Price Transparency Tool: Who Uses It, And How They Shop For Care

(2016) Anna D. Sinaiko et al.   HEALTH AFFAIRS

Trend Toward High-Volume Hospitals and the Influence on Complications in Knee and Hip Arthroplasty

(2016) Nicholas C. Laucis et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

Increasing the Value of Healthcare: Improving Mortality While Reducing Cost in Bariatric Surgery

(2015) Ryan C. Broderick et al.   OBESITY SURGERY

Clinical Characteristics and Outcomes of Medicare Patients Undergoing Total Hip Arthroplasty, 1991-2008

(2011) Peter Cram   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION